Literature DB >> 7755572

Photoaffinity labelling of cyanomethaemoglobin with derivatives of tryptophan and 5-bromotryptophan.

M Li1, Z Lin, M E Johnson.   

Abstract

Tryptophan and 5-bromotryptophan (5-BrTrp) are relatively potent inhibitors of sickle-haemoglobin polymerization. The binding sites of these compounds to normal and sickle haemoglobin (HBA and HBS) have been suggested, but not firmly established, through the use of spin-labelled derivatives and/or computer modeling. In the present study we approached the problem by utilizing the technique of photoaffinity labelling. The cyanomet forms of HBA and HBS were subjected to photoaffinity labelling with N alpha-(4-azidotetrafluorobenzoyl)tryptophan and N alpha-(1-ethyl-2-diazomalonyl)-5-bromotryptophan respectively. Both irradiated samples of HBA and HBS were denatured, digested with trypsin, and then separated by reversed-phase HPLC. A labelled tryptic peptide was isolated from the photolabelling of HBS with N alpha-(1-ethyl-2-diazomalonyl)-5-bromotryptophan. The peptide was identified to be Val1(alpha)-Lys7(alpha), with the label attached to Val1(alpha), by virtue of amino acid analysis and sequencing, in conjunction with fast-atom-bombardment MS. The binding mode of N alpha-(1-ethyl-2-diazomalonyl)-5-bromotryptophan is proposed and its relevance to the potency of the 5-BrTrp-based anti-sickling agents is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7755572      PMCID: PMC1136870          DOI: 10.1042/bj3080251

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Sickle hemoglobin aggregation: a new class of inhibitors.

Authors:  J R Votano; M Gorecki; A Rich
Journal:  Science       Date:  1977-06-10       Impact factor: 47.728

2.  Effects of amino acids on gelation kinetics and solubility of sickle hemoglobin.

Authors:  C T Noguchi; A N Schechter
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

3.  Noncovalent inhibitors of sickle hemoglobin gelation: effects of aryl-substituted alanines.

Authors:  W N Poillon
Journal:  Biochemistry       Date:  1982-03-16       Impact factor: 3.162

4.  Preparation of derivatives of ferrous and ferric hemoglobin.

Authors:  E E Di Iorio
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Rational approaches to chemotherapy: antisickling agents.

Authors:  I M Klotz; D N Haney; L C King
Journal:  Science       Date:  1981-08-14       Impact factor: 47.728

6.  Hemoglobin Sunshine Seth - alpha 2 (94 (G1) Asp replaced by His) beta 2.

Authors:  W A Schroeder; J B Shelton; J R Shelton; D Powars
Journal:  Hemoglobin       Date:  1979       Impact factor: 0.849

7.  Physiological and x-ray studies of potential antisickling agents.

Authors:  D J Abraham; M F Perutz; S E Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Inhibition of sickle hemoglobin gelation by amino acids and related compounds.

Authors:  C T Noguchi; A N Schechter
Journal:  Biochemistry       Date:  1978-12-12       Impact factor: 3.162

9.  The first example of a deletion in the human alpha chain: hemoglobin Boyle Heights or alpha 2 6 (A4) Asp----to O beta 2.

Authors:  C S Johnson; W A Schroeder; J B Shelton; J R Shelton
Journal:  Hemoglobin       Date:  1983       Impact factor: 0.849

10.  Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease.

Authors:  J R Votano; J Altman; M Wilchek; M Gorecki; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.